You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced/ metastatic RCC (mRCC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Japanese RCC Patients Treated With Avelumab Plus Axitinib as

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Jan 18, 2023

Advanced Renal Cell Carcinoma Trial in Heilbronn (IVAC)

Recruiting
  • Advanced Renal Cell Carcinoma
  • IVAC
  • Heilbronn, Germany
    SLK Kliniken Heilbronn, Klinik für Innere Medizin III: Hämatolog
Nov 30, 2022

Renal Cell Carcinoma Trial (Pembrolizumab)

Completed
Has Results
  • Renal Cell Carcinoma
  • Pembrolizumab
  • (no location specified)
Aug 17, 2022

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 2, 2022

Renal Cell Carcinoma Trial (Pembrolizumab, Axitinib, Sunitinib)

Active, not recruiting
Has Results
  • Renal Cell Carcinoma
  • Pembrolizumab
  • +2 more
  • (no location specified)
Aug 17, 2022

Unresectable, Locally Advanced Or Metastatic Renal Cell

Completed
  • Locally Advanced or Metastatic Renal Cell Carcinoma
  • Cabozantinib monotherapy
  • All authorized TKI monotherapies in advanced RCC per FDA label in advanced RCC
  • The Woodlands, Texas
    McKesson Life Sciences
Nov 11, 2021

Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC Trial in Australia, United States (RO7502175, Atezolizumab)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • +10 more
  • Aurora, Colorado
  • +6 more
Jan 4, 2023

Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

Not yet recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +2 more
Jun 27, 2022

Urine Omics Predicting IO Therapy Responses in mRCC Patients

Recruiting
  • Metastatic Renal Cell Carcinoma
  • No intervention required
  • Taipei, Taiwan
    National Taiwan University Hospital
Jan 18, 2022

Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)

Active, not recruiting
  • Advanced Solid Tumors
  • +15 more
  • (no location specified)
Sep 16, 2022

Describe Kidney Cancer Patient Population Treatment, and Results

Not yet recruiting
  • Renal Cell Cancer
  • +6 more
    • (no location specified)
    May 2, 2022

    Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

    Completed
    Has Results
    • Carcinoma
    • Renal Cell
    • London, United Kingdom
      Pfizer UK
    Jan 9, 2023

    Advanced Solid Tumor, Advanced/ Metastatic Renal Cell Carcinoma (RCC), Microsatellite Iinstability-high (MSI-H) or Mismatch

    Active, not recruiting
    • Advanced Solid Tumor
    • +3 more
    • TP-1454 monotherapy
    • TP-1454 combination therapy
    • Phoenix, Arizona
    • +8 more
    Nov 18, 2022

    Renal Cell Carcinoma (RCC) Trial in Worldwide (Pembrolizumab, Epacadostat, Sunitinib)

    Active, not recruiting
    Has Results
    • Renal Cell Carcinoma (RCC)
    • Scottsdale, Arizona
    • +139 more
    Jun 3, 2022

    Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC) Trial in Iowa City (Selenomethionine (SLM), Axitinib)

    Recruiting
    • Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Sep 13, 2021

    Renal Cell Carcinoma, Metastatic, Renal Cell Cancer, Recurrent Trial in Germany (Concomitant coaching)

    Recruiting
    • Renal Cell Carcinoma, Metastatic
    • Renal Cell Cancer, Recurrent
    • Concomitant coaching
    • Regensburg, Bayern, Germany
    • +33 more
    Dec 21, 2021

    Hepatocellular Carcinoma, Renal Cell Carcinoma Trial in Australia, New Zealand (APL-501, APL-101, Nivolumab)

    Terminated
    • Hepatocellular Carcinoma
    • Renal Cell Carcinoma
    • APL-501
    • +2 more
    • Albury, New South Wales, Australia
    • +8 more
    May 3, 2022

    Locally Advanced or Metastatic Renal Cell Carcinoma Trial in Worldwide (Cabozantinib)

    Active, not recruiting
    • Locally Advanced or Metastatic Renal Cell Carcinoma
    • Salzburg, Austria
    • +39 more
    Jan 18, 2023

    Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK

    Recruiting
    • RCC
    • Metastatic Renal Cell Carcinoma
    • Immunological and tumour characterization
    • Naples, Italy
      IRCCS Istituto Nazionale Tumori di Napoli
    Sep 10, 2020

    Metastatic sRCC Trial in Philadelphia (Avelumab, Gemcitabine)

    Recruiting
    • Metastatic sRCC
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jul 22, 2021

    Metastatic Renal Cell Carcinoma Trial in Worldwide (Ipilimumab plus nivolumab, Standard Therapy)

    Recruiting
    • Metastatic Renal Cell Carcinoma
    • Ipilimumab plus nivolumab
    • Standard Therapy
    • Gent, Belgium
    • +40 more
    Feb 7, 2022

    International Multicentric Study ARON-1

    Recruiting
    • Metastatic Renal Cell Carcinoma (mRCC)
    • pembrolizumab plus axitinib
    • Macerata, Italy
      Ospedale di Macerata, UOC Oncologia
    Aug 30, 2022

    Multiomics Approach in Metastatic Clear Renal Cell Carcnoma

    Recruiting
    • Metastatic Clear Cell Renal Carcinoma
    • CT scan
    • Plasma collection
    • Milan, Mi, Italy
      Istituto Tumori
    Mar 13, 2023

    Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)

    Active, not recruiting
    Has Results
    • Metastatic Cancer
    • +9 more
    • Mobile, Alabama
    • +19 more
    Aug 1, 2022

    Metastatic Solid Tumor, Advanced Solid Tumor Trial in United States (WTX-124, Pembrolizumab)

    Recruiting
    • Metastatic Solid Tumor
    • Advanced Solid Tumor
    • Scottsdale, Arizona
    • +4 more
    Aug 3, 2022